• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合多器官切除在局部进展期胃癌治疗中的应用

Application of combined multiple organ resection in the treatment of locally advanced gastric cancer.

作者信息

He Beibei, Li Shengwen, Guo Yaming, Li Song, Zhu Wenjun, Wang Xinyi, Chen Baozhang, Wu Shile

机构信息

Department of General Surgery, Qinghai Provincial People's Hospital, Xining City, Qinghai Province, China.

出版信息

Medicine (Baltimore). 2025 Aug 29;104(35):e44020. doi: 10.1097/MD.0000000000044020.

DOI:10.1097/MD.0000000000044020
PMID:40898562
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12401299/
Abstract

This study analyzes the application value of extended multi-organ resection in the treatment of locally advanced gastric cancer, and to provide reference for the clinical diagnosis and treatment of locally advanced gastric cancer patients. From January 2016 to April 2022, 64 cases of locally advanced gastric cancer admitted to our hospital were analyzed retrospectively. Combined multiple organ resection was used as the treatment strategy, and the general information and surgical data of patients were analyzed to evaluate the prognosis of extended multi-organ resection in the treatment of locally advanced gastric cancer and the factors affecting these clinical outcomes. A total of 64 patients with locally advanced gastric cancer were included, including 34 males and 30 females, with an average age of 57.28 ± 12.27 years. Among them, combined pancreatectomy was performed in 25 cases, splenectomy in 20 cases, hepatectomy in 12 cases, pancreaticoduodenectomy in 5 cases, pancreaticoduodenectomy and right colon resection in 1 case, and colon resection in 1 case. The average operation time was 159.64 ± 25.19 minutes and the median intraoperative bleeding was 150 mL. All 64 patients achieved R0 resection, and all patients were followed up. Postoperative complications occurred in 18 cases, of which the mortality rate was 16.67% (3/18). The 1-year, 3-year, and 5-year survival rates were 59.4%, 35.9%, and 14.6%, respectively. It is feasible to treat locally advanced gastric cancer by extended combined organ resection. As long as the indications are strictly grasped, the overall prognosis of patients can be improved.

摘要

本研究分析扩大多器官切除术在局部进展期胃癌治疗中的应用价值,为局部进展期胃癌患者的临床诊治提供参考。回顾性分析2016年1月至2022年4月我院收治的64例局部进展期胃癌患者。采用联合多器官切除术作为治疗策略,分析患者的一般资料和手术数据,以评估扩大多器官切除术治疗局部进展期胃癌的预后及影响这些临床结局的因素。共纳入64例局部进展期胃癌患者,其中男性34例,女性30例,平均年龄57.28±12.27岁。其中,25例行联合胰切除术,20例行脾切除术,12例行肝切除术,5例行胰十二指肠切除术,1例行胰十二指肠切除术联合右半结肠切除术,1例行结肠切除术。平均手术时间为159.64±25.19分钟,术中中位出血量为150 mL。64例患者均实现R0切除,所有患者均获随访。术后并发症发生18例,其中死亡率为16.67%(3/18)。1年、3年和5年生存率分别为59.4%、35.9%和14.6%。采用扩大联合器官切除术治疗局部进展期胃癌是可行的。只要严格掌握适应证,就能改善患者的总体预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f707/12401299/091ee250fcc9/medi-104-e44020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f707/12401299/dfac049eaa28/medi-104-e44020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f707/12401299/abb31234b0ff/medi-104-e44020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f707/12401299/091ee250fcc9/medi-104-e44020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f707/12401299/dfac049eaa28/medi-104-e44020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f707/12401299/abb31234b0ff/medi-104-e44020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f707/12401299/091ee250fcc9/medi-104-e44020-g003.jpg

相似文献

1
Application of combined multiple organ resection in the treatment of locally advanced gastric cancer.联合多器官切除在局部进展期胃癌治疗中的应用
Medicine (Baltimore). 2025 Aug 29;104(35):e44020. doi: 10.1097/MD.0000000000044020.
2
Resection versus other treatments for locally advanced pancreatic cancer.局部晚期胰腺癌的手术切除与其他治疗方法对比
Cochrane Database Syst Rev. 2014 Feb 27;2014(2):CD010244. doi: 10.1002/14651858.CD010244.pub2.
3
[Application research of endoscopic-laparoscopic regional gastric resection combined with sentinel lymph node basin dissection in patients with early gastric cancer].内镜-腹腔镜区域胃切除术联合前哨淋巴结清扫在早期胃癌患者中的应用研究
Zhonghua Wai Ke Za Zhi. 2025 Jul 1;63(7):587-596. doi: 10.3760/cma.j.cn112139-20250117-00034.
4
[Clinical application of pelvic floor resection in combined pelvic organ resection for locally advanced or locally recurrent rectal cancer].盆底切除术在局部晚期或局部复发性直肠癌联合盆腔脏器切除术中的临床应用
Zhonghua Wei Chang Wai Ke Za Zhi. 2025 Jul 25;28(7):743-750. doi: 10.3760/cma.j.cn441530-20250424-00169.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
[Long-term oncological safety of robotic total gastrectomy for locally advanced proximal gastric cancer: a 5-year noninferiority comparison based on the FUGES-014 study].机器人全胃切除术治疗局部进展期近端胃癌的长期肿瘤学安全性:基于FUGES-014研究的5年非劣效性比较
Zhonghua Wei Chang Wai Ke Za Zhi. 2025 Aug 25;28(8):886-894. doi: 10.3760/cma.j.cn441530-20250610-00218.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Systematic review of pancreaticoduodenectomy for locally advanced gastric cancer.局部进展期胃癌行胰十二指肠切除术的系统评价。
Gastric Cancer. 2012 Sep;15 Suppl 1:S108-15. doi: 10.1007/s10120-011-0086-5. Epub 2011 Aug 26.
9
Oncologic Effectiveness and Safety of Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: Meta-analysis of Randomized Controlled Trials.全胃切除术治疗近端胃癌时脾切除术的肿瘤学疗效与安全性:随机对照试验的Meta分析
Anticancer Res. 2018 Jun;38(6):3609-3617. doi: 10.21873/anticanres.12635.
10
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial.局部进展期胃或胃食管交界腺癌患者行D2胃切除术后围手术期或术后辅助使用奥沙利铂联合S-1与奥沙利铂联合卡培他滨的疗效比较(RESOLVE):一项随机、开放标签、3期试验的最终报告
Lancet Oncol. 2025 Mar;26(3):312-319. doi: 10.1016/S1470-2045(24)00676-4. Epub 2025 Feb 11.

本文引用的文献

1
[Screening for cancer of the colon and rectum A review on incidence, mortality, cost and benefit].[结肠癌和直肠癌筛查:发病率、死亡率、成本与效益综述]
Laeknabladid. 2021 Sep;107(9):398-405. doi: 10.17992/lbl.2021.09.65.
2
[Prognosis and Related Factors of Patients with Pathological Complete Response after Neoadjuvant Therapy for Gastric Cancer].[胃癌新辅助治疗后病理完全缓解患者的预后及相关因素]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021 Aug;43(4):571-578. doi: 10.3881/j.issn.1000-503X.13260.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Advantages of Splenic Hilar Lymph Node Dissection in Proximal Gastric Cancer Surgery.脾门淋巴结清扫在近端胃癌手术中的优势
J Gastric Cancer. 2020 Mar;20(1):19-28. doi: 10.5230/jgc.2020.20.e10. Epub 2020 Mar 20.
5
The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.全球、地区和国家 195 个国家/地区 1990-2017 年胃癌负担:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):42-54. doi: 10.1016/S2468-1253(19)30328-0. Epub 2019 Oct 21.
6
Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review.近期进展:胃癌的外科治疗进展:综述。
Med Sci Monit. 2019 May 13;25:3537-3541. doi: 10.12659/MSM.916475.
7
The Prognosis Value of Lymphatic Vessel Invasion in pN0 Gastric Cancer Patients with Insufficient Examined Lymph Nodes.淋巴结检出数目不足的 pN0 期胃癌患者中淋巴管浸润的预后价值
J Gastrointest Surg. 2020 Feb;24(2):299-306. doi: 10.1007/s11605-018-04101-z. Epub 2019 Jan 22.
8
Advanced gastric cancer: the value of surgery.进展期胃癌:手术的价值
Acta Biomed. 2018 Dec 17;89(8-S):110-116. doi: 10.23750/abm.v89i8-S.7897.
9
[Intra-abdominal and retroperitoneal sarcomas].[腹内及腹膜后肉瘤]
Chirurg. 2016 Mar;87(3):255-66; quiz 267. doi: 10.1007/s00104-016-0156-7.
10
Palliative distal gastrectomy offers no survival benefit over gastrojejunostomy for gastric cancer with outlet obstruction: retrospective analysis of an 11-year experience.对于伴有幽门梗阻的胃癌患者,姑息性远端胃切除术与胃空肠吻合术相比,并无生存获益:一项11年经验的回顾性分析
World J Surg Oncol. 2014 Nov 29;12:364. doi: 10.1186/1477-7819-12-364.